Sei Investments Co. Has $12.12 Million Position in Certara, Inc. (NASDAQ:CERT)

Sei Investments Co. increased its position in shares of Certara, Inc. (NASDAQ:CERT) by 2.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,137,612 shares of the company’s stock after buying an additional 28,809 shares during the quarter. Sei Investments Co. owned 0.71% of Certara worth $12,116,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Wasatch Advisors LP grew its holdings in shares of Certara by 22.4% during the 3rd quarter. Wasatch Advisors LP now owns 9,015,941 shares of the company’s stock worth $105,577,000 after purchasing an additional 1,651,076 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in Certara by 169.0% during the fourth quarter. Bank of New York Mellon Corp now owns 1,995,071 shares of the company’s stock worth $21,248,000 after buying an additional 1,253,385 shares in the last quarter. Teacher Retirement System of Texas increased its holdings in Certara by 13.9% in the 4th quarter. Teacher Retirement System of Texas now owns 4,557,951 shares of the company’s stock valued at $48,542,000 after buying an additional 557,348 shares during the period. Raymond James Financial Inc. acquired a new position in shares of Certara in the 4th quarter valued at $3,628,000. Finally, Edgestream Partners L.P. lifted its holdings in shares of Certara by 140.3% during the 4th quarter. Edgestream Partners L.P. now owns 365,708 shares of the company’s stock worth $3,895,000 after acquiring an additional 213,549 shares during the period. Institutional investors and hedge funds own 73.96% of the company’s stock.

Certara Stock Down 2.1 %

Shares of NASDAQ CERT opened at $9.91 on Friday. Certara, Inc. has a 12-month low of $9.41 and a 12-month high of $19.18. The firm’s 50-day simple moving average is $12.43 and its 200 day simple moving average is $11.45. The company has a quick ratio of 2.86, a current ratio of 2.86 and a debt-to-equity ratio of 0.28. The company has a market cap of $1.60 billion, a price-to-earnings ratio of -49.55, a price-to-earnings-growth ratio of 9.29 and a beta of 1.60.

Analyst Ratings Changes

CERT has been the topic of a number of analyst reports. Stephens reissued an “overweight” rating and issued a $17.00 target price on shares of Certara in a research note on Thursday, February 27th. Barclays increased their target price on Certara from $12.00 to $13.00 and gave the stock an “equal weight” rating in a report on Friday, February 28th. TD Cowen assumed coverage on Certara in a research note on Thursday, February 27th. They issued a “buy” rating and a $16.00 price target on the stock. Finally, William Blair reiterated a “market perform” rating on shares of Certara in a research note on Thursday, February 27th. Four research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, Certara currently has an average rating of “Moderate Buy” and a consensus target price of $15.83.

Certara Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.